Lyra Therapeutics, Inc. Profile Avatar - Palmy Investing

Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo techn…

Biotechnology
US, Watertown [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Lyra Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Lyra Therapeutics, Inc. can't present revenue by segment

End of LYRA's Analysis
CIK: 1327273 CUSIP: 55234L105 ISIN: US55234L1052 LEI: - UEI: -
Secondary Listings
LYRA has no secondary listings inside our databases.